White label – Pompe disease - ClinicalTrials.eu

A study of PF-08634404 and sigvotatug vedotin in patients with advanced solid tumors

Recruiting

1 1 1
Investigated Diseases:
Investigated Drugs:
- HUMANISED IGG1 MONOCLONAL ANTIBODY AGAINST PD-L1 CONJUGATED TO MONOMETHYL AURISTATIN E VIA A VALINE-CITRULLINE LINKER
- SIGVOTATUG VEDOTIN
A study to evaluate the effectiveness of tarlatamab in patients with extensive-stage small cell lung cancer that has progressed after prior treatment and who have limited health status

Recruiting

2 1 1
Investigated Diseases:
Investigated Drugs:
- Tarlatamab
A study to evaluate the use of leflutrozole to improve semen quality in men with non-obstructive azoospermia

Recruiting

2 1 1
Investigated Diseases:
- Infertility male
A study to compare the effectiveness and safety of subcutaneous frexalimab versus intravenous frexalimab in adults with multiple sclerosis

Recruiting

3 1 1
Investigated Drugs:
- Frexalimab
A study comparing the effectiveness of vorolanib and aflibercept in patients with diabetic macular edema

Recruiting

3 1 1 1
Investigated Drugs:
- VOROLANIB
- Aflibercept
A study to evaluate the safety and tolerability of tinlarebant in patients with Stargardt disease

Recruiting

3 1 1
Investigated Diseases:
- Stargardt’s disease
Investigated Drugs:
- Tinlarebant
A study of PF-08634404 and a drug combination for adult patients with extensive-stage small cell lung cancer

Recruiting

4 1 1 1
Investigated Diseases:
- Small cell lung cancer extensive stage
Investigated Drugs:
A study to evaluate the effects of zenagamtide on weight and pain in patients with overweight or obesity and knee osteoarthritis

Recruiting

3 1
Investigated Diseases:
A study to evaluate the efficacy and safety of zenagamtide in people with overweight or obesity and knee osteoarthritis

Recruiting

3 1
Investigated Diseases:
A study to evaluate the effect of valproic acid in women of reproductive age with adenomyosis

Recruiting

2 1 1
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies